ArticleNPJ Parkinson's disease2025

Rational selection of the monoclonal α-synuclein antibody amlenetug (Lu AF82422) for the treatment of α-synucleinopathies.

Pekka Kallunki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.